Paris, February 6th – Innovacom, a pioneer in innovation venture capital in France, acquires a stake in the capital of the company Avicenna.ai through its fund technocom3. Avicennai.ai is a start-up specialized in the development of software dedicated to helping to the diagnosis of emergency pathologies by radiologists.
Specialist in supporting early-stage start-ups and breakthrough innovations at strong technological dimension, Innovacom announced an investment in the first-round funding of the young innovative company Avicenna.ai. This capital increase of 2.7 million euros with the support of CEMAG Invest will allow to Avicenna.ai to accelerate the development of its software solutions dedicated to the detection of emergency pathologies on sectional images from scanners. After intensive research studies, these high-performance tools are now ready for daily clinical applications.
Founded in 2018 by Cyril DI GRANDI, co-founder of Olea Medical, and the American radiologist Peter CHANG, Co-Director of the Department of Artificial Intelligence Applied to Medicine from the University of Irvine, Avicenna.ai’s ambition is to become one of the leaders of the detection of emergency injuries, such as stroke, heart attack, hemorrhages, aneurysm ruptures or abdominal pain.
These new solutions provide radiologists with a faster and more reliable interpretation capability to any time of the day or night. Avicenna.ai will thus allow a greater number of patients to access innovative, targeted and less invasive treatments.
“With Innovacom’s support, Avicenna.ai will be able to draw on real prospects and benefit from the expertise of its network in access to the main industrial markets and of the medical sector in the United States and Europe,” said Cyril DI GRANDI.
“A radiologist has about three seconds to analyze an image in a context extremely tense where every second counts. Avicenna.ai’s solutions are a great help and valuable in emergency diagnostics. They bring a major breakthrough in a sensitive medical field.
Innovacom is enthusiastic about supporting the team of Avicenna.ai in this second entrepreneurial adventure following our successful investment in Olea Medical”, added Vincent DELTRIEU, partner of Innovacom.
Presse release pdf : 2020-02-06_Press Release Avicenna.ai 1 – eng